We serve Chemical Name:tert-Butyl-(3-aminobutyl)carbamat CAS:878799-20-3 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:tert-Butyl-(3-aminobutyl)carbamat
CAS.NO:878799-20-3
Synonyms:1-Boc-amino-butyl-3-amine;1-N-BOC-BUTANE-1,3-DIAMINE;tert-butyl (3-aminobutyl)carbamate;tert-Butyl-(3-aminobutyl)carbamat;1,1-dimethylethyl (3-aminobutyl)carbamate;2-amino-4-{tert-butoxycarbonyl(2-tert-butyldimethylsiloxyethyl)amino}butane;2-Methyl-2-propanyl (3-aminobutyl)carbamate;Carbamic acid, N-(3-aminobutyl)-, 1,1-dimethylethyl ester
Molecular Formula:C9H20N2O2
Molecular Weight:188.267
HS Code:2924199090
Physical and Chemical Properties:
Melting point:N/A
Boiling point:282.6±23.0 °C at 760 mmHg
Density:1.0±0.1 g/cm3
Index of Refraction:1.456
PSA:64.35000
Exact Mass:188.152481
LogP:1.11
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like 1-Boc-amino-butyl-3-amine chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Carbamic acid, N-(3-aminobutyl)-, 1,1-dimethylethyl ester physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,1,1-dimethylethyl (3-aminobutyl)carbamate Use and application,Carbamic acid, N-(3-aminobutyl)-, 1,1-dimethylethyl ester technical grade,usp/ep/jp grade.
Related News: The Company intends to further develop candidates from Mindset Families 2-4 with the goal of selecting additional lead candidates in the near future. 1-(4-((3-hydroxy-13,24,34,43,53,63-hexaoxin-2-yl)tetraoxidaneyl)-13,24,33,44,53,63-hexaoxin-2-yl)-14-pentaoxidan-1-one manufacturers Immunocompromised people account for roughly 2.7% of U.S. adults including patients who’ve received an organ transplant, living with HIV or have received active or recent treatment for cancer, Oliver said. (4H)-dihydrobenzothiazine suppliers McNamara joined GSK from Novartis in 2015 when the two companies combined their OTC portfolios into a joint venture managed by GSK. He became head of GSK consumer health in 2016, taking the baton from Walmsley as she moved up the command chain to CEO of the entire group. Novartis in 2018 backed out of the collab, and after taking full control of the venture, GSK formed a new JV with Pfizer in 2019. (R)-5-allyl-5-(sec-butyl)pyrimidine-2,4,6(1H,3H,5H)-trione vendor & factory.
